ghk-cu injection vs topical effectiveness Reducing Redness & Inflammation with Copper Peptides – Vitali Skincare GHK-CU Before and After Pictures
Description
PMID 32533046 Ho W, et al
The large phase 3 EVOKE trials in people who already had mild cognitive impairment or mild Alzheimers did not slow the disease, but the observational signal for prevention is strong, with real-world data from more than a million patients showing that semaglutide users have a 40 to 70 percent lower risk of a first Alzheimers diagnosis than users of other diabetes drugs
Separate published data shows dramatic reductions in liver fat and significant improvements in insulin sensitivity
Are the reported FOXO4-DRI side effects permanent or temporary
Neuropeptides (2004) 38:13540
